Other

Dataset Information

0

A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells


ABSTRACT: Non-small cell lung cancer (NSCLC) patients carrying an epidermal growth factor receptor (EGFR) mutation have an initial favorable clinical response to the tyrosine kinase inhibitors (TKIs). Unfortunately, rapid resistance occurs mainly because of genetic alterations, including amplification of the hepatocyte growth factor receptor (MET) and its abnormal activity. The RNA post-transcriptional modifications that contribute to aberrant expression of MET in cancer are largely under-investigated and among them is the adenosine-to-inosine (A-to-I) RNA editing of microRNAs. A reduction of A-to-I editing in position 5 of miR-411-5p has been identified in several cancers, including NSCLC. In this study, thanks to cancer-associated gene expression analysis, we assessed the effect of the edited miR-411-5p on NSCLC cell lines. We found that edited miR-411-5p directly targets MET and negatively affects the itogen-activated protein kinases (MAPKs) pathway. Considering the predominant role of the MAPKs pathway on TKI resistance, we generated NSCLC EGFR mutated cell lines resistant to TKI inhibitors and evaluated the effect of edited miR-411-5p overexpression. We found that the edited miR-411-5p reduces proliferation and induces apoptosis, promoting EGFR TKI response in NSCLC-resistant cells\

ORGANISM(S): Homo sapiens

PROVIDER: GSE221334 | GEO | 2023/04/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA913917 | ENA
2015-03-07 | GSE66604 | GEO
2023-10-09 | PXD025361 | Pride
2017-05-01 | GSE94405 | GEO
2018-07-16 | GSE114406 | GEO
2014-06-01 | E-GEOD-31852 | biostudies-arrayexpress
2014-06-01 | GSE31852 | GEO
2022-02-11 | E-MTAB-11404 | biostudies-arrayexpress
2023-05-31 | PXD034228 | JPOST Repository
2012-05-29 | E-GEOD-38310 | biostudies-arrayexpress